Keyphrases
Bullous Pemphigoid
100%
Population-based Study
95%
Psoriasis
79%
Population-based Cohort Study
53%
Hidradenitis Suppurativa
53%
Retrospective Cohort Study
50%
Pemphigus
47%
Atopic Dermatitis
45%
Confidence Interval
43%
COVID-19
34%
Pyoderma Gangrenosum
33%
Pemphigus Vulgaris
25%
Israel
23%
Alopecia Areata
23%
Population-based Case-control Study
22%
Adjusted Odds Ratio
21%
Control Subjects
20%
Odds Ratio
20%
Autoimmune Bullous Disease
20%
Psoriatic Patients
18%
COVID-19 Risk
18%
Hospitalization
18%
Epidermolysis Bullosa Acquisita
17%
Rheumatoid Arthritis
17%
Acne Keloidalis nuchae
16%
Dipeptidyl peptidase-4 (DPP-4)
16%
COVID-19 Pandemic
16%
Adjusted Hazard Ratio
16%
Schizophrenia
15%
Autoantibodies
15%
Bidirectional Association
14%
Immunological Characteristics
14%
COVID-19 Mortality
13%
Clinical Characteristics
13%
BP180
13%
Large Cohort
13%
Systemic Corticosteroids
13%
IgA Pemphigus
13%
Comorbid
12%
Comorbidity
12%
Blister
11%
Multivariate Analysis
11%
Mucous Membrane Pemphigoid
11%
Solid Malignancies
11%
Treatment Outcome
11%
Amyloidosis
11%
Observational Prospective Study
11%
Infantile Hemangioma
11%
COVID-19 Hospitalization
11%
Ankylosing Spondylitis
11%
Medicine and Dentistry
COVID-19
65%
Bullous Pemphigoid
55%
Hidradenitis Suppurativa
40%
Disease
38%
Psoriasis
33%
Odds Ratio
31%
Retrospective Cohort Study
28%
Cohort Analysis
27%
Atopic Dermatitis
26%
Pemphigus
23%
Prospective Study
22%
Systematic Review
22%
Dermatosis
19%
Hazard Ratio
17%
Acne Keloidalis Nuchae
16%
Pemphigus vulgaris
15%
Bullous Disease
14%
Prevalence
13%
Lichen Planus
12%
IgA Pemphigus
12%
Autoantibodies
12%
Pemphigoid
11%
Epidermolysis Bullosa Acquisita
11%
Dipeptidyl Peptidase-4 Inhibitor
11%
Case-Control Study
11%
Cicatricial Pemphigoid
11%
Thyroid Disease
11%
Cross Sectional Study
9%
Cohort Effect
8%
Autoantigen
8%
Immunoglobulin A
7%
Consultation
7%
Logistic Regression Analysis
7%
Dermatitis
7%
Nephropathy
7%
Symptom
7%
Biological Product
6%
Rhinophyma
6%
Pediatrics
6%
Inflammatory Infiltrate
6%
Pemphigus foliaceus
6%
Nodular Melanoma
6%
Corticosteroid
6%
Metabolic Syndrome
6%
Teledermatology
6%
Infection
5%
Erythema
5%
Patient Referral
5%
Hepatitis C
5%
Craniofacial Malformation
5%